| NDC Code | 0003-2187-13 |
|---|
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0003-2187-13) / 15 mL in 1 VIAL, SINGLE-USE |
|---|
| Product NDC | 0003-2187 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Orencia |
|---|
| Non-Proprietary Name | Abatacept |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20090101 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125118 |
|---|
| Manufacturer | E.R. Squibb & Sons, L.L.C. |
|---|
| Substance Name | ABATACEPT |
|---|
| Strength | 250 |
|---|
| Strength Unit | mg/15mL |
|---|
| Pharmacy Classes | Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC] |
|---|